Stock A016580 WHAN IN PHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Whan In Pharm Co.,Ltd.

Equities

A016580

KR7016580003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
13,710 KRW +0.07% Intraday chart for Whan In Pharm Co.,Ltd. -3.45% -8.84%
2023 Whan In Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2015 Whanin Pharmaceutical Co. Ltd.(KOSE:A016580) added to Russell Global Index CI

Business Summary

Whan In Pharm Co.,Ltd. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The Company also involves in the real estate rental business.

Number of employees: 553

Sales per Business

KRW in Million2022Weight2023Weight Delta
Psychotropic Drug
76.7 %
155,251 78.0 % 176,808 76.7 % +13.89%
Antipyretic Analgesic
7.0 %
6,023 3.0 % 16,043 7.0 % +166.34%
Other
7.0 %
16,121 8.1 % 16,024 7.0 % -0.60%
Circulatory System Medicine
5.2 %
12,052 6.1 % 12,029 5.2 % -0.18%
Peptic Ulcer Medicine
2.3 %
5,299 2.7 % 5,309 2.3 % +0.20%
Osteoporosis Treatment
1.8 %
4,189 2.1 % 4,180 1.8 % -0.22%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
198,935 100.0 % 230,394 100.0 % +15.81%

Managers

Managers TitleAgeSince
Won-Bum Lee CEO
 Chief Executive Officer 49 05-12-31
Kwang-Sik Lee CEO
 Chief Executive Officer 76 78-05-31
Ho-Chul Shin CTO
 Chief Tech/Sci/R&D Officer 51 -
Dong-Soo Lee PRN
 Corporate Officer/Principal 59 -
Seung-Sik Lee SAM
 Sales & Marketing 62 -
Yun-Bae Kim PRN
 Corporate Officer/Principal 65 12-11-30

Members of the board

Members of the board TitleAgeSince
Kwang-Sik Lee CEO
 Chief Executive Officer 76 78-05-31
Won-Bum Lee CEO
 Chief Executive Officer 49 05-12-31
Kyung-Seok Cho BRD
 Director/Board Member 50 16-03-17
Kyu-Hyeong Jang BRD
 Director/Board Member 48 -
Jeom-Gyu Lee BRD
 Director/Board Member 58 -
Sang-Won Hwang BRD
 Director/Board Member 46 22-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,600,070 10,994,916 ( 59.11 %) 3,333,000 ( 17.92 %) 59.11 %

Shareholders

NameEquities%Valuation
Kwang-Sik Lee
20.00 %
3,720,394 20.00 % 40 M ₩
WHAN IN PHARM CO.,LTD.
17.92 %
3,333,000 17.92 % 36 M ₩
National Pension Service of Korea
6.042 %
1,123,855 6.042 % 12 M ₩
Won-Bum Lee
3.275 %
609,067 3.275 % 7 M ₩
HYUNDAI PHARMACEUTICAL CO., LTD.
2.624 %
488,000 2.624 % 5 M ₩
DONGWHA PHARM.CO.,LTD
1.882 %
350,000 1.882 % 4 M ₩
KYUNG DONG PHARMACEUTICAL CO., LTD.
1.059 %
197,000 1.059 % 2 M ₩
Pension Reserves Investment Management Board
0.0382 %
7,100 0.0382 % 76 683 ₩
Dimensional Fund Advisors Ltd.
0.0377 %
7,007 0.0377 % 75 678 ₩
DFA Australia Ltd.
0.008376 %
1,558 0.008376 % 16 827 ₩

Holdings

NameEquities%Valuation
WHAN IN PHARM CO.,LTD.
17.92%
 3,333,000 17.92% 35,997,633 $

Company contact information

Whan In Pharmaceutical Co., Ltd.

Whanin Building 11, Beobwon-ro 6-gil

05809, Seoul

+

http://www.whanin.com
address Whan In Pharm Co.,Ltd.(A016580)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Ratings for Whan In Pharm Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13,710 KRW
Average target price
21,000 KRW
Spread / Average Target
+53.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
WHAN IN PHARM CO.,LTD. Stock Whan In Pharm Co.,Ltd.
-8.84% 151M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.73% 44.1B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+16.20% 21.97B
CIPLA LIMITED Stock Cipla Limited
+7.75% 13.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+6.06% 13.22B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+33.60% 11.36B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.59% 7.07B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+7.71% 5.23B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A016580 Stock
  4. Company Whan In Pharm Co.,Ltd.